semaglutide arrhythmia For patients with obesity and atrial fibrillation, GLP-1 receptor agonist drugs may be the weight loss approach that better addresses their arrhythmia, observational data suggested. https://www.medpagetoday.com/cardiology/ arrhythmias/120327 Semaglutide and AFib: Heart Safety

Semaglutide (aka Ozempic or Wegovy) has become ubiquitous because of established benefits in diabetes and obesity but SELECT showed that the wonder drug should be considered in those who are obese with established atherosclerotic CV disease (ASCVD.) In March of 2024 the FDA approved a new indication for Wegovy based on the SELECT trial to reduce the risk of CV death, stroke, and heart attack in adults with cardiovascular disease and either obese or overweight Lets take a look at the group SELECT enrolled to see if you or the patient in front of you is similar to those enrolled

Oxidative metabolism, ros and no under oxygen deprivation

You can manage semaglutide-related nausea with a few simple strategies, such as adjusting your diet, staying hydrated, and taking anti-nausea medication

"With the approval of Opzelura in nonsegmental vitiligo, Incyte has once again delivered a treatment to patients with high unmet medical need who previously had no approved therapies," Herv Hoppenot, Incyte's chief executive officer, said in a press release